Determining the relationship between Helicobacter pylori eradication treatment and blood sugar control in type 2 diabetic patients

Phase 3

Recruiting

• Conditions: Condition 1: Helicobacter pylori. Condition 2: Type 2 diabetes mellitus.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; Type 2 diabetes mellitus; B96.81

• Registration Number: IRCT20220920056004N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

All asymptomatic diabetic patients whose Helicobacter pylori test is positive
Informed consent of the patient regarding participation in the study

Exclusion Criteria

People with kidney failure, anemia and hemoglobinopathy
History of antibiotic use in the last one month and proton pump inhibitor in the last two weeks
Patients who had a history of treatment for Helicobacter infection in the past
Patients who have hb a1c more than 10
Diabetic patients needing insulin treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determination of blood sugar. Timepoint: The level of HbA1c and FBS before starting the treatment of Helicobacter pylori infection and after proving its eradication with the determination of Helicobacter pylori antigen in stool by PCR method, HbA1c is measured again three months after the start of treatment and the difference between HbA1c and FBS before and after treatment is compared. Method of measurement: blood test.